Engagement of the natural cytotoxicity receptors NKp30, NKp44, and/or NKp46 from CD56bright NK cells is required to suppress autologous T cells from untreated patients with RRMS in vitro (23). The gene discussed is NCR2; the disease is relapsing-remitting multiple sclerosis.